• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤癌切除术后面部重建的长期外观相关结果

Long-Term Appearance-Related Outcomes of Facial Reconstruction After Skin Cancer Resection.

作者信息

Gulati Arushi, Grekin Roy, Neuhaus Isaac, Saylor Drew, Yu Siegrid, Park Andrea, Seth Rahul, Knott P Daniel

机构信息

Department of Otolaryngology-Head and Neck Surgery and University of California, San Francisco, California, USA.

Department of Dermatology, University of California, San Francisco, California, USA.

出版信息

Facial Plast Surg Aesthet Med. 2023 Jul-Aug;25(4):344-350. doi: 10.1089/fpsam.2022.0170. Epub 2022 Oct 25.

DOI:10.1089/fpsam.2022.0170
PMID:36282777
Abstract

Aesthetic outcomes of facial reconstruction after skin cancer resection (RSCR) may affect long-term quality of life. : To evaluate postoperative patient perceptions of skin cancer defect reconstruction using patient-reported outcome measures. Patients who underwent RSCR from 2016 to 2021 completed validated FACE-Q scales, including Satisfaction with Facial Appearance (SFA), Scar Appearance, and Appearance-Related Distress (ARD). Scores were scaled 0-100 and compared. Sixty-one respondents completed the survey at a median of 3.0 (interquartile range: 1.6-4.1) years post-treatment. The majority had basal cell carcinomas ( = 41, 67%) and nasal defects ( = 40, 66%). Patients who received either revision surgery or office-based procedures to improve scarring reported lower satisfaction with scar appearance (65.8 ± 31.8 vs. 80.1 ± 20.8,  = 0.048). Dissatisfaction with scar appearance was correlated with decreased SFA (mean score: 76.6 ± 24.5;  = 0.44,  = 0.0004) and greater ARD (mean score: 23.8 ± 24.3;  = -0.66,  < 0.0001). Younger patients were also more likely to experience ARD ( = -0.54, 95% confidence interval: [-0.96, -0.12,  = 0.014). SFA and ARD did not differ by operative factors, including reconstruction type, or single- versus multistage reconstruction. Although overall SFA after RSCR is high, regardless of reconstruction type, decreased satisfaction is correlated to poorer psychosocial function. Younger patients and those requiring revision procedures may be at greatest risk.

摘要

皮肤癌切除术后面部重建(RSCR)的美学效果可能会影响长期生活质量。目的:使用患者报告的结局指标评估患者对皮肤癌缺损重建术后的看法。2016年至2021年接受RSCR的患者完成了经过验证的FACE-Q量表,包括对面部外观的满意度(SFA)、疤痕外观和与外观相关的困扰(ARD)。分数范围为0至100并进行比较。61名受访者在治疗后中位时间3.0年(四分位间距:1.6 - 4.1年)完成了调查。大多数患者患有基底细胞癌(n = 41,67%)且存在鼻部缺损(n = 40,66%)。接受修复手术或门诊手术以改善疤痕的患者对疤痕外观的满意度较低(65.8 ± 31.8 vs. 80.1 ± 20.8,P = 0.048)。对疤痕外观的不满与SFA降低相关(平均得分:76.6 ± 24.5;P = 0.44,r = 0.0004)以及更高的ARD相关(平均得分:23.8 ± 24.3;P = -0.66,r < 0.0001)。年轻患者也更有可能经历ARD(P = -0.54,95%置信区间:[-0.96, -0.12],P = 0.014)。SFA和ARD在手术因素方面没有差异,包括重建类型或单阶段与多阶段重建。尽管无论重建类型如何,RSCR后的总体SFA较高,但满意度降低与较差的心理社会功能相关。年轻患者和那些需要修复手术的患者可能风险最大。

相似文献

1
Long-Term Appearance-Related Outcomes of Facial Reconstruction After Skin Cancer Resection.皮肤癌切除术后面部重建的长期外观相关结果
Facial Plast Surg Aesthet Med. 2023 Jul-Aug;25(4):344-350. doi: 10.1089/fpsam.2022.0170. Epub 2022 Oct 25.
2
Pressure Masks for Facial Scar Treatment after Oncological Reconstruction: Long-Term Patient Satisfaction and Quality of Life.压力面罩用于肿瘤重建后面部瘢痕治疗:长期患者满意度和生活质量。
Facial Plast Surg. 2024 Feb;40(1):36-45. doi: 10.1055/a-2035-4468. Epub 2023 Feb 14.
3
Patient-Reported Aesthetic and Psychosocial Outcomes After Microvascular Reconstruction for Head and Neck Cancer.头颈癌微血管重建术后患者报告的美学和心理社会结果
JAMA Otolaryngol Head Neck Surg. 2021 Dec 1;147(12):1035-1044. doi: 10.1001/jamaoto.2021.1563.
4
Appearance-related psychosocial distress following facial skin cancer surgery using the FACE-Q Skin Cancer.面部皮肤癌手术后与容貌相关的心理社会困扰:采用 FACE-Q 皮肤癌量表评估
Arch Dermatol Res. 2019 Nov;311(9):691-696. doi: 10.1007/s00403-019-01957-2. Epub 2019 Jul 23.
5
To see or not to see: Impact of viewing facial skin cancer defects prior to reconstruction.看还是不看:重建术前查看面部皮肤癌缺损的影响
Arch Dermatol Res. 2021 Dec;313(10):847-853. doi: 10.1007/s00403-021-02187-1. Epub 2021 Jan 30.
6
Nasal skin reconstruction: Time to rethink the reconstructive ladder?鼻腔皮肤重建:是否需要重新思考重建阶梯?
J Plast Reconstr Aesthet Surg. 2022 Mar;75(3):1239-1245. doi: 10.1016/j.bjps.2021.11.028. Epub 2021 Nov 14.
7
FACE-Q Skin Cancer Module for measuring patient-reported outcomes following facial skin cancer surgery.用于评估面部皮肤癌手术后患者报告结局的 FACE-Q 皮肤癌模块。
Br J Dermatol. 2018 Jul;179(1):88-94. doi: 10.1111/bjd.16671. Epub 2018 May 23.
8
Patient-reported Aesthetic Satisfaction following Facial Skin Cancer Surgery Using the FACE-Q Skin Cancer Module.使用FACE-Q皮肤癌模块评估面部皮肤癌手术后患者报告的美学满意度。
Plast Reconstr Surg Glob Open. 2019 Sep 30;7(9):e2423. doi: 10.1097/GOX.0000000000002423. eCollection 2019 Sep.
9
Patient Satisfaction Following Primary Closure or Second Intention Healing After Conventional Nasal Skin Cancer Excision: A Cross-sectional Cohort Study.常规鼻部皮肤癌切除术后一期缝合或二期愈合后患者满意度的横断面队列研究。
Dermatol Surg. 2024 Mar 1;50(3):247-255. doi: 10.1097/DSS.0000000000004037. Epub 2023 Nov 27.
10
Importance of physical appearance in patients with skin cancer.外貌在皮肤癌患者中的重要性。
Dermatol Surg. 2015 Feb;41(2):183-8. doi: 10.1097/DSS.0000000000000253.

引用本文的文献

1
Non-Surgical Rhinoplasty After Nasal Skin Cancer Reconstruction: Enhancing Esthetic Outcomes.鼻皮肤癌重建术后的非手术隆鼻术:改善美学效果。
J Clin Med. 2025 Jul 31;14(15):5394. doi: 10.3390/jcm14155394.
2
"High-risk" tumors of the lip treated with external beam radiotherapy and high-dose-rate brachytherapy: Long-term outcome.采用外照射放疗和高剂量率近距离放疗治疗的唇部“高危”肿瘤:长期疗效
Head Neck. 2025 Feb;47(2):586-598. doi: 10.1002/hed.27936. Epub 2024 Sep 26.
3
Aesthetic Evaluation of Facial Scars in Patients Undergoing Surgery for Basal Cell Carcinoma: A Prospective Longitudinal Pilot Study and Validation of POSAS 2.0 in the Lithuanian Language.
基底细胞癌手术患者面部瘢痕的美学评估:一项前瞻性纵向试点研究及立陶宛语版POSAS 2.0的验证
Cancers (Basel). 2024 May 30;16(11):2091. doi: 10.3390/cancers16112091.